welbournes

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (21/07/2023) announced the following list of price concessions for July 2023: Please note CPE is still in discussion with DHSC on several other lines of concern, including other [...]

The post July 2023 Price Concessions 3rd Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Atomoxetine 40mg and 60mg capsules. MSN/2023/068 Tier 2 – medium impact Date of issue 21st July 2023 Atomoxetine 40mg and 60mg capsules will be out of stock from late July 2023 until September 2023 Other strengths and formulations of atomoxetine remain [...]

The post Medicine Supply Notification: Atomoxetine 40mg and 60mg capsules appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (18/07/2023) announced the following list of price concessions for July 2023: Drug Pack size Price concession Atorvastatin 40mg tablets 28 £2.25 Chloramphenicol 1% eye ointment 4 £5.18 Clarithromycin [...]

The post July 2023 Price Concessions 2nd Update appeared first on Community Pharmacy England.

National Patient Safety Alert: Shortage of GLP-1 receptor agonists National Patient Safety Alert Reference Number: NatPSA/2023/008/DHSC Date issued: 18th July 2023 Brief description of the problem There are very limited, intermittent supplies of all glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Supplies are not expected to stabilise to meet full market demand until at least mid-2024.  [...]

The post National Patient Safety Alert DHSC: Shortage of GLP-1 receptor agonists appeared first on Community Pharmacy England.

Date issued: 13 July 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Sabril 500 mg film-coated tablets & Sabril 500 mg granules for oral solution. Sabril 500 mg film-coated tablets Pl 04425/0171 Batch number Expiry date Pack size First distributed 2989A April 2025 100 02/08/22 2988D [...]

The post MHRA Class 2 Medicines Recall: Sabril 500mg film-coated tablets and 500mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi) appeared first on Community Pharmacy England.